Market Movers: AT&Ts Data Breach Impact, Insider Moves at Nextera, and More
Generated by AI AgentAinvest Market Brief
Wednesday, Jul 24, 2024 6:30 pm ET1min read
NEE--
NEP--
T--
1. At&T (NYSE: T)
At&T gained solidly by 5.19%. AT&T reported Q2 revenue of $29.8 billion, slightly below market expectations, with non-GAAP EPS matching predictions at $0.57. The company experienced significant network interruptions and a substantial data breach affecting 110 million customers. Plans include expanding connected learning centers by 2027.
2. Nextera Energy (NYSE: NEE)
Nextera Energy gained solidly by 4.59%. Nextera Energy reported insider transactions on July 23, 2024. BMO Capital, Barclays, and Citigroup updated their ratings and price targets for Nextera. Nextera's Q2 2024 financial results will be reported on July 24, 2024.
3. Thermo Fisher Scientific (NYSE: TMO)
Thermo Fisher Scientific gained solidly by 4.08%. Thermo Fisher Scientific will report its Q2 2024 financial results on July 24, 2024. The company has replaced its China President. Analysts maintain various ratings: Evercore ISI with Outperform at a $600 target, Barclays with Equal-Weight at a $600 target, and Jefferies with Buy at a $650 target.
4. Bristol-Myers Squibbmpany (NYSE: BMY)
Bristol-Myers Squibbmpany gained solidly by 3.96%. Bristol-Myers Squibb will report its Q2 financial results on 2024-07-26. Deutsche Bank and Barclays maintain a hold rating on the company with price targets of $45.00 and $41.00 respectively. Bristol-Myers Squibb's PD-1 antibody drug has filed for a new indication in China.
5. Tennectivity Ltd. (NYSE: TEL)
Tennectivity Ltd. gained solidly by 3.61%. HSBC downgraded TE Connectivity to Hold, setting a price target of $162.00. Vertical Research initiated coverage with a Hold rating and a $155.00 price target. B of A Securities maintained a Buy rating with a $170.00 target.
At&T gained solidly by 5.19%. AT&T reported Q2 revenue of $29.8 billion, slightly below market expectations, with non-GAAP EPS matching predictions at $0.57. The company experienced significant network interruptions and a substantial data breach affecting 110 million customers. Plans include expanding connected learning centers by 2027.
2. Nextera Energy (NYSE: NEE)
Nextera Energy gained solidly by 4.59%. Nextera Energy reported insider transactions on July 23, 2024. BMO Capital, Barclays, and Citigroup updated their ratings and price targets for Nextera. Nextera's Q2 2024 financial results will be reported on July 24, 2024.
3. Thermo Fisher Scientific (NYSE: TMO)
Thermo Fisher Scientific gained solidly by 4.08%. Thermo Fisher Scientific will report its Q2 2024 financial results on July 24, 2024. The company has replaced its China President. Analysts maintain various ratings: Evercore ISI with Outperform at a $600 target, Barclays with Equal-Weight at a $600 target, and Jefferies with Buy at a $650 target.
4. Bristol-Myers Squibbmpany (NYSE: BMY)
Bristol-Myers Squibbmpany gained solidly by 3.96%. Bristol-Myers Squibb will report its Q2 financial results on 2024-07-26. Deutsche Bank and Barclays maintain a hold rating on the company with price targets of $45.00 and $41.00 respectively. Bristol-Myers Squibb's PD-1 antibody drug has filed for a new indication in China.
5. Tennectivity Ltd. (NYSE: TEL)
Tennectivity Ltd. gained solidly by 3.61%. HSBC downgraded TE Connectivity to Hold, setting a price target of $162.00. Vertical Research initiated coverage with a Hold rating and a $155.00 price target. B of A Securities maintained a Buy rating with a $170.00 target.
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet